HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Extract Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Search for Related Content Social Bookmarking                What's this?

Errata

In the first sentence under conclusions on page 2067, "one-third of all older individuals" should read "one-third of all older individuals with diabetes." The paragraph containing the correct sentence is shown here:

The present study shows that about one-third of all older individuals with diabetes remain undiagnosed. In this study of healthier older adults, men, those with a history of hypertension, and those with high BMI and large waist circumference were at the highest risk of having undiagnosed diabetes. Screening for diabetes may be more efficient among these subgroups, especially among individuals with combinations of these risk factors, in which the NNTS [number needed to screen] to identify one undiagnosed diabetic individual was lowest.

Rolka DB, Venkat Narayan KM, Thompson TJ, Goldman D, Lindenmayer J, Alich K, Bacall D, Benjamin EM, Lamb B, Stuart DO, Engelgau MM: Performance of recommended screening tests for undiagnosed diabetes and dysglycemia. Diabetes Care 24:1899–1903, 2001

In the first complete sentence on page 1903, "336 ÷ (336 + 552) = 29.8%" should read "336 ÷ (336 + 552) = 37.8%." The sentence containing the correct calculation is shown here:

The projected positive predictive value (proportion of actual cases among those who have positive tests) would be 336 ÷ (336 + 552) = 37.8%.

Hotta N, Toyota T, Matsuoka K, Shigeta Y, Kikkawa R, Kaneko T, Takahashi A, Sugimura K, Koike Y, Ishii J, Sakamoto N, the SNK-860 Diabetic Neuropathy Study Group: Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy: a 52-week multicenter placebo-controlled double-blind parallel group study. Diabetes Care 24:1776–1782, 2001

In Table 2 on page 1779 of the above article, the units of measure under the row headings "F wave minimum latency in median" and "F wave minimum latency in tibial" were listed incorrectly because of a composition error. The correct table is given on the following page.

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				W. Sun, P. J. Oates, J. B. Coutcher, C. Gerhardinger, and M. Lorenzi A selective aldose reductase inhibitor of a new structural class prevents or reverses early retinal abnormalities in experimental diabetic retinopathy. Diabetes, October 1, 2006; 55(10): 2757 - 2762. [Abstract] [Full Text] [PDF]

This Article Extract Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Search for Related Content Social Bookmarking                What's this?